Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOw Countries VEdolizumab in CD Study)

NCT02646683 is registered in ClinicalTrials.gov with Geert D'Haens as lead sponsor.

NCT NCT02646683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02646683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOw Countries VEdolizumab in CD Study)
Lead sponsor
Geert D'Haens
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2015
Completion date
May 26, 2023
Enrollment
260 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease